Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban for progressive ischemic stroke
ChiCTR1900027700Phase 4Not yet recruiting
- Sponsor
- Liaoning Provincial People's Hospital
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tirofiban in ischemic stroke, sponsored by Liaoning Provincial People's Hospital. Primary endpoint: NIHSS score. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR1900027700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027700.